Esketamine-based treatment, depression-specific metacognitive training, and their combination in treatment-resistant depression: 6-month trajectories of depressive symptoms and rumination in a multicenter observational study.
European archives of psychiatry and clinical neuroscience · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansFemaleDepressive Disorder, Treatment-ResistantMaleAntidepressive AgentsMiddle AgedAdultKetamineMetacognitionRumination, CognitiveCognitive Behavioral TherapyPsychiatric Status Rating ScalesTreatment OutcomeDepression-specific metacognitive trainingEsketamineLongitudinal studyReal-world psychiatryRuminationTreatment-resistant depression
Come citare questo studio
Vassilis Martiadis, Fabiola Raffone, Danilo Atripaldi, Enrico Pessina, Carlo Ignazio Cattaneo, Serena Testa, Concetta Iaccarino, Giacomo d'Andrea, Clara Cavallotto, Miriam Olivola, Bernardo Dell'Osso. (2026). Esketamine-based treatment, depression-specific metacognitive training, and their combination in treatment-resistant depression: 6-month trajectories of depressive symptoms and rumination in a multicenter observational study.. European archives of psychiatry and clinical neuroscience. DOI: 10.1007/s00406-026-02361-4
Consulta la pubblicazione originale ↗